Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:646 (29 September), doi:10.1136/bmj.39349.591296.59
Simon Collins, treatment advocate, HIV i-Base, London, and International Treatment Preparedness Coalition, Brook K Baker, Northeastern University School of Law, Health Global Access Project, Gregg Gonsales, AIDS and Rights Alliance for Southern Africa, Marco Gomes, Global Youth Coalition on HIV/AIDS
Contact S Collins simon.collins@i-base.org.uk
| The first 150 words of the full text of this article appear below. |
Roger England has launched yet another broadside attack on programmes for priority diseases in poor countries (BMJ 2007;335:565 doi: 10.1136/bmj.39335.520463.94 and 2007;334:344 doi: 10.1136/bmj.39113.402361.94). In his latest Personal View, he claims that "disease specific global programmes [are] not the way to help Africa," instead that they cause "big problems for recipients," and that money for HIV/AIDS is "the worst." He claims that off-budget money leads to distortions; that there are duplications of plans, operations, and monitoring; and that priority disease programmes are neither cost effective nor sustainable.
His evidence that little is being achieved is one statistic: HIV prophylaxis is reaching only 9% (actually it is 11%) of pregnancies of HIV positive women. He blames the warped prioritisation of disease programmes on international lobby groups from rich countries.
England's prescription for change says that (1) governments must stop funding global programmes that do not go through countries' planning
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+